Tech Company Financing Transactions
Aperiomics Funding Round
VentureSouth, Pipeline Capital and Propel(x) invested in a $1.8 million Series A funding round for Aperiomics. This VC investment round was announced on 8/23/2019.
Transaction Overview
Company Name
Announced On
8/23/2019
Transaction Type
Venture Equity
Amount
$1,800,000
Round
Series A
Investors
Proceeds Purpose
The new funding will enable it to make major investments in research and development that will improve [its] technology -- making it easier to use and improving access to vital metagenomic information.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
45925 Horseshoe Dr. 170
Sterling, VA 20166
USA
Sterling, VA 20166
USA
Phone
Website
Email Address
Overview
Until Aperiomics' service was launched, detection of pathogens that cause infection was a hit-and-miss process that left patients and clinicians frustrated. Too often, people were sick for months or years before their clinicians could make accurate diagnoses and begin the healing process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Crystal Icenhour
Chief Technical Officer
Alvin Chen
VP - Bus. Development
Collin Smith
VP - Operations
Wynemah Fuller
Browse more venture capital transactions:
Prev: 8/23/2019: Molecula venture capital transaction
Next: 8/23/2019: DemystData venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs